Dashboard
Weak Long Term Fundamental Strength with a -135.58% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.14
- The company has been able to generate a Return on Equity (avg) of 1.90% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
Risky - Negative Operating Profits
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 295 Cr (Micro Cap)
NA (Loss Making)
40
0.00%
-0.14
-1.92%
0.82
Total Returns (Price + Dividend) 
Latest dividend: 12.5 per share ex-dividend date: Aug-20-2024
Risk Adjusted Returns v/s 
Returns Beta
News

National Peroxide Falls to 52-Week Low of Rs.500 Amidst Prolonged Downtrend
National Peroxide’s stock price reached a new 52-week and all-time low of Rs.500 today, marking a significant milestone in its recent market performance. The stock has been on a declining trajectory over the past three days, reflecting a cumulative return of -3.73% during this period, and continues to trade below all key moving averages.
Read More
National Peroxide Stock Falls to 52-Week Low of Rs.500
National Peroxide has reached a new 52-week low, closing at Rs.500, marking a significant decline amid a broader market rally. The stock has been under pressure for several sessions, reflecting ongoing challenges within the commodity chemicals sector.
Read More
National Peroxide Stock Hits All-Time Low Amid Prolonged Downtrend
National Peroxide’s shares have reached an all-time low, reflecting a sustained period of subdued performance across multiple financial metrics. The stock’s recent trading levels place it just 1.74% above its 52-week low, underscoring the challenges faced by the company within the commodity chemicals sector.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2025 | Source : BSENewspaper Advertisement for the unaudited financial results of the Company for the Quarter ended and Half Year ended September 30 2025.
Approval Of The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025
03-Nov-2025 | Source : BSEApproval of the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025
Board Meeting Outcome for Approval Of The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.
03-Nov-2025 | Source : BSEThis is to inform you that the Board of Directors of National Peroxide Limited (formerly known as NPL Chemicals Limited) (the Company) at their meeting held today i.e. on November 03 2025 had inter-alia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025.
Corporate Actions 
No Upcoming Board Meetings
National Peroxide Ltd has declared 125% dividend, ex-date: 20 Aug 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Nowrosjee Wadia And Sons Limited (30.78%)
None
24.83%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 2.45% vs -9.55% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -56.18% vs 113.71% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.64% vs -6.39% in Sep 2024
Growth in half year ended Sep 2025 is -77.78% vs -35.64% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -13.85% vs -11.41% in Mar 2024
YoY Growth in year ended Mar 2025 is -113.40% vs -57.49% in Mar 2024






